Ocean Capital Management LLC increased its stake in Insulet Co. (NASDAQ:PODD – Get Rating) by 4.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,581 shares of the medical instruments supplier’s stock after acquiring an additional 69 shares during the […]
Insulet (NASDAQ:PODD – Get Rating) and Femasys (NASDAQ:FEMY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of current recommendations for Insulet and […]
Fred Alger Management LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 565,632 shares of the medical instruments supplier’s stock after selling 66,419 shares during the quarter. Insulet comprises about 0.9% […]
Insulet (NASDAQ:PODD – Get Rating) and Medigus (NASDAQ:MDGS – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Insider and Institutional Ownership 9.2% of Medigus shares are held by institutional […]
Osterweis Capital Management Inc. lifted its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 4.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 16,068 shares of the medical instruments supplier’s stock after purchasing an additional 743 shares during the quarter. Osterweis Capital Management […]